7 months ago
43 GOOD Vision Technologies Co., Limited, a group in Ophthalmic Optics & Diagnostics, is introducing a corneal topography solution designed for use in patients as young as four years old. The company announced the solution at the International Exhibition of Inventions of Geneva.
Supported by Hong Kong Science and Technology Parks Corporation’s Incu-Bio Programme, a platform that supports the growth and development of biomedical tech start-ups in Hong Kong, GOOD Vision has developed a novel corneal toporgrapher that aims to empower eye care practitioners with an efficient, accurate, and personalised option to enhance patient care says the company.
GOOD Vision says the development aligns closely with the World Health Organisation’s 2030 targets for effective eye care coverage, addressing gaps in diagnosing and treating refractive errors.
Astigmatism affects 40.4% of adults and 14.9% of children worldwide according to the company. The company also says that there was a notable 1.5-fold increase in astigmatism cases in Hong Kong during the COVID-19 lockdown, which it says underscores the need for advanced diagnostic tools such as GOOD Vision’s corneal topographer – K-Shape.
GOOD Vision says the topographer outperforms existing devices with its flexibility, compact size, utlisation of normative data from Chinese populations, and affordability.
By investigating subtle topographic changes on the cornea’s front surface, the device allows for early diagnosis of vision conditions such as astigmatism and corneal ectasia. This supports practitioners in assessing risks and facilitating timely interventions, which are critical for visual development in children.
“At GOOD Vision, we’re setting new standards in eye care with K-Shape. Based on our extensive study of over 900 Chinese children, our topographer is set to advance corneal reshaping, ensuring early intervention and personalised patient care. Our research revealed key insights into astigmatism and its broader impact, driving us to develop a tool that detects early corneal changes for prompt treatment, essential for healthy vision,” said Dr. Jason Lau, the Technical Director at GOOD Vision.
“As optometrists are in short supply globally, K-Shape offers a way for practitioners to deliver precise, efficient care, particularly in early childhood screenings and clinical practice. Our diverse team, spanning university researchers to engineers, has worked tirelessly to bring K-ShapeTM from concept to market. We proudly showcase this game-changing technology at the International Exhibition of Inventions of Geneva.”
K-Shape incorporates advanced AI algorithms to identify corneal irregularities, ensuring precise image capture and facilitating on-the-spot data analysis. The company says this AI integration increases efficiency in eye examinations and streamlines the workflow in clinical settings.
